These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1954641)

  • 1. Effectiveness of the C Cap in promoting prescription refill compliance among patients with glaucoma.
    Sclar DA; Skaer TL; Chin A; Okamoto MP; Nakahiro RK; Gill MA
    Clin Ther; 1991; 13(3):396-400. PubMed ID: 1954641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of a medication alarm device on patient compliance with topical pilocarpine.
    Laster SF; Martin JL; Fleming JB
    J Am Optom Assoc; 1996 Nov; 67(11):654-8. PubMed ID: 8979657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence and adherence with topical glaucoma therapy.
    Nordstrom BL; Friedman DS; Mozaffari E; Quigley HA; Walker AM
    Am J Ophthalmol; 2005 Oct; 140(4):598-606. PubMed ID: 16226511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of levobunolol and timolol in the treatment of chronic open-angle glaucoma and chronic ocular hypertension].
    Savelsbergh-Fillette MP; Demailly P
    J Fr Ophtalmol; 1988; 11(8-9):587-90. PubMed ID: 2906644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health literacy and adherence to glaucoma therapy.
    Muir KW; Santiago-Turla C; Stinnett SS; Herndon LW; Allingham RR; Challa P; Lee PP
    Am J Ophthalmol; 2006 Aug; 142(2):223-6. PubMed ID: 16876500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.
    Mastropasqua L; Carpineto P; Ciancaglini M; Gallenga PE
    Ophthalmology; 1999 Mar; 106(3):550-5. PubMed ID: 10080213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use.
    Robin AL; Novack GD; Covert DW; Crockett RS; Marcic TS
    Am J Ophthalmol; 2007 Oct; 144(4):533-40. PubMed ID: 17686450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?
    Robin AL; Covert D
    Ophthalmology; 2005 May; 112(5):863-8. PubMed ID: 15878067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoring sensitivity to timolol after long-term drift in primary open-angle glaucoma.
    Gandolfi SA
    Invest Ophthalmol Vis Sci; 1990 Feb; 31(2):354-8. PubMed ID: 2406218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial administration of adrenergic antagonist and agonist ("pulsatile therapy") reduces the incidence of long-term drift to timolol in humans.
    Gandolfi SA; Vecchi M
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):684-8. PubMed ID: 8595970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma.
    Schenker H; Maloney S; Liss C; Gormley G; Hartenbaum D
    Clin Ther; 1999 Jan; 21(1):138-47. PubMed ID: 10090431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.
    Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
    Ophthalmology; 2009 Feb; 116(2):191-9. PubMed ID: 19084273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.
    Lesk MR; Koulis T; Sampalis F; Sampalis JS; Bastien NR
    Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discontinuation rates of topical glaucoma medications in a managed care population.
    Shaya FT; Mullins CD; Wong W; Cho J
    Am J Manag Care; 2002 Aug; 8(10 Suppl):S271-7. PubMed ID: 12188170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study.
    Quigley HA; Friedman DS; Hahn SR
    Ophthalmology; 2007 Sep; 114(9):1599-606. PubMed ID: 17572498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drugs reactions associated with glaucoma medications.
    Reyes E; Izquierdo NJ; Blasini M
    Bol Asoc Med P R; 1997; 89(4-6):51-5. PubMed ID: 9284599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timolol and guanethidine plus adrenaline in combination in the treatment of chronic open angle glaucoma.
    Mills KB; Vogel R; Jacobs N
    Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 6)():621-4. PubMed ID: 3866411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
    Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
    Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levobunolol compared with timolol for the control of elevated intraocular pressure.
    Geyer O; Lazar M; Novack GD; Lue JC; Duzman E
    Ann Ophthalmol; 1986 Oct; 18(10):289-90, 292. PubMed ID: 3535611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dorzolamide/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group.
    Sverrisson T; Gross R; Pearson J; Rusk C; Adamsons I
    J Glaucoma; 1999 Oct; 8(5):315-24. PubMed ID: 10529932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.